Xlife Sciences AG (SWX:XLS)
Switzerland
· Delayed Price · Currency is CHF 24.80
-1.20 (-4.62%)
Last updated: Apr 24, 2025
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 149.29 million as of April 24, 2025. Its market cap has decreased by -39.83% in one year.
Market Cap
149.29M
Enterprise Value
298.79M
Revenue
990.27K
Ranking
n/a
PE Ratio
9.97
Stock Price
24.80
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 149.29M, a decrease of -37.92%. That is a compound annual growth rate of -13.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 136.65M | -6.30% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 204.44B |
| Novartis AG | 171.98B |
| Lonza Group AG | 38.79B |
| Alcon | 37.28B |
| Galderma Group AG | 18.65B |
| Straumann Holding AG | 15.45B |
| Sonova Holding AG | 14.13B |
| Sandoz Group AG | 14.01B |